EA201270421A1 - 1,2-дигидро-2-оксохинолиновые соединения в качестве лигандов рецептора 5-нт - Google Patents

1,2-дигидро-2-оксохинолиновые соединения в качестве лигандов рецептора 5-нт

Info

Publication number
EA201270421A1
EA201270421A1 EA201270421A EA201270421A EA201270421A1 EA 201270421 A1 EA201270421 A1 EA 201270421A1 EA 201270421 A EA201270421 A EA 201270421A EA 201270421 A EA201270421 A EA 201270421A EA 201270421 A1 EA201270421 A1 EA 201270421A1
Authority
EA
Eurasian Patent Office
Prior art keywords
compounds
dihydro
receptor
oxohinoline
ligands
Prior art date
Application number
EA201270421A
Other languages
English (en)
Other versions
EA020227B1 (ru
Inventor
Рамакришна Нироджи
Абдул Рашид Мохаммед
Иштияк Ахмад
Прадип Джаяраджан
Нагарадж Вишвоттам Кандикере
Анил Карбхари Схинде
Рама Састри Камбхампати
Геопинадх Бхирапунени
Йотхсна Равула
Срирамахандра Мурти Патнала
Венкатесварлу Джасти
Original Assignee
Сувен Лайф Сайенсиз Лимитед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Сувен Лайф Сайенсиз Лимитед filed Critical Сувен Лайф Сайенсиз Лимитед
Publication of EA201270421A1 publication Critical patent/EA201270421A1/ru
Publication of EA020227B1 publication Critical patent/EA020227B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4704—2-Quinolinones, e.g. carbostyril
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings

Abstract

Настоящее изобретение относится к новым 1,2-дигидро-2-оксохинолиновым соединениям формулы (I) и их производным, пролекарствам, таутомерам, стереоизомерам, полиморфам, сольватам, гидратам, метаболитам, N-оксидам, фармацевтически приемлемым солям и содержащим их композициям. Настоящее изобретение также относится к способу получения вышеуказанных новых соединений и их производных, пролекарств, таутомеров, стереоизомеров, полиморфов, сольватов, гидратов, метаболитов, N-оксидов, фармацевтически приемлемых солей и содержащих их композиций. Соединения по настоящему изобретению используют в лечении/профилактике различных расстройств, которые опосредованы активностью рецептора 5-НТ.
EA201270421A 2009-09-14 2009-12-29 1,2-дигидро-2-оксохинолиновые соединения в качестве лигандов рецептора 5-нт EA020227B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN2224CH2009 2009-09-14
PCT/IN2009/000745 WO2011030349A1 (en) 2009-09-14 2009-12-29 L -dihydro-2-oxoquinoline compounds a 5-ht4 receptor ligands

Publications (2)

Publication Number Publication Date
EA201270421A1 true EA201270421A1 (ru) 2012-09-28
EA020227B1 EA020227B1 (ru) 2014-09-30

Family

ID=42126528

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201270421A EA020227B1 (ru) 2009-09-14 2009-12-29 1,2-дигидро-2-оксохинолиновые соединения в качестве лигандов рецептора 5-нт

Country Status (17)

Country Link
US (1) US8598204B2 (ru)
EP (1) EP2507225B1 (ru)
JP (1) JP5540099B2 (ru)
KR (1) KR101386354B1 (ru)
CN (1) CN102639526B (ru)
AU (1) AU2009352490B2 (ru)
CA (1) CA2771885C (ru)
DK (1) DK2507225T3 (ru)
EA (1) EA020227B1 (ru)
ES (1) ES2578628T3 (ru)
HK (1) HK1173140A1 (ru)
IL (1) IL218525A (ru)
MX (1) MX2012002608A (ru)
NZ (1) NZ598505A (ru)
SG (1) SG178557A1 (ru)
WO (1) WO2011030349A1 (ru)
ZA (1) ZA201201429B (ru)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2423212B1 (en) * 2009-04-24 2016-06-01 Nissan Chemical Industries, Ltd. Process for production of 2-azaadamantane compound from bicyclocarbamate compound
KR20120044978A (ko) 2009-06-19 2012-05-08 아보트 러보러터리즈 디아자호모아다만탄 유도체 및 이들의 사용 방법
CN104125960A (zh) * 2011-12-22 2014-10-29 康内克斯生命科学私人有限公司 氮杂金刚烷的衍生物及其用途
RU2557249C1 (ru) * 2014-03-03 2015-07-20 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Самарский государственный технический университет" Способ получения 1-гидрокси-4-адамантанона
CN106957252B (zh) * 2014-11-19 2019-11-19 连云港恒运药业有限公司 一种质子泵抑制剂中间体及其制备方法
SG11202003664TA (en) 2017-11-30 2020-05-28 Arrakis Therapeutics Inc Nucleic acid-binding photoprobes and uses thereof
WO2019111218A1 (en) 2017-12-08 2019-06-13 Cadila Healthcare Limited Novel heterocyclic compounds as irak4 inhibitors

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994008965A1 (en) 1992-10-16 1994-04-28 Smithkline Beecham Plc N-alkylpiperidinyl-4-methyl carboxylic esters/amides of condensed ring systems as 5-ht4 receptor antagonists
JPH07324087A (ja) * 1994-04-04 1995-12-12 Taisho Pharmaceut Co Ltd 複素環化合物
US7405235B2 (en) * 2001-05-04 2008-07-29 Paratek Pharmaceuticals, Inc. Transcription factor modulating compounds and methods of use thereof
TWI351282B (en) * 2004-04-07 2011-11-01 Theravance Inc Quinolinone-carboxamide compounds as 5-ht4 recepto
US7407966B2 (en) * 2004-10-07 2008-08-05 Epix Delaware, Inc. Thienopyridinone compounds and methods of treatment
ATE441646T1 (de) 2004-11-05 2009-09-15 Theravance Inc 5-ht4-rezeptoragonistenverbindungen
US7419989B2 (en) 2004-12-22 2008-09-02 Theravance, Inc. Indazole-carboxamide compounds
BRPI0607456A2 (pt) 2005-02-22 2009-09-08 Pfizer derivados de oxindol como agonistas do receptor 5ht4
JP4970290B2 (ja) 2005-02-25 2012-07-04 ファイザー株式会社 ベンズイソキサゾール誘導体
US7446114B2 (en) * 2005-03-02 2008-11-04 Theravance, Inc. Quinolinone compounds as 5-HT4 receptor agonists
US7906532B2 (en) 2005-07-22 2011-03-15 Pfizer Inc. Indazole derivatives
US8557994B2 (en) * 2009-07-27 2013-10-15 Daljit Singh Dhanoa Deuterium-enriched pyridinonecarboxamides and derivatives

Also Published As

Publication number Publication date
CN102639526B (zh) 2014-06-04
ES2578628T3 (es) 2016-07-28
IL218525A0 (en) 2012-07-31
US20120277216A1 (en) 2012-11-01
EP2507225A1 (en) 2012-10-10
IL218525A (en) 2014-12-31
KR20120081986A (ko) 2012-07-20
DK2507225T3 (en) 2016-07-04
US8598204B2 (en) 2013-12-03
HK1173140A1 (en) 2013-05-10
SG178557A1 (en) 2012-03-29
EA020227B1 (ru) 2014-09-30
EP2507225B1 (en) 2016-06-01
CA2771885A1 (en) 2011-03-17
AU2009352490B2 (en) 2013-06-20
JP5540099B2 (ja) 2014-07-02
KR101386354B1 (ko) 2014-04-16
WO2011030349A1 (en) 2011-03-17
AU2009352490A1 (en) 2012-04-19
MX2012002608A (es) 2012-04-02
ZA201201429B (en) 2012-10-31
NZ598505A (en) 2013-01-25
JP2013504561A (ja) 2013-02-07
CN102639526A (zh) 2012-08-15
CA2771885C (en) 2014-04-08

Similar Documents

Publication Publication Date Title
MX2013005535A (es) Compuesto de 3- (amino-aril) -piridina.
EA201591239A1 (ru) Замещенные фталазин-1(2h)-оновые производные в качестве селективных ингибиторов поли(адф-рибоза)полимеразы-1
EA201070864A1 (ru) Новые гетероциклические соединения
MY155653A (en) Triazine compounds as p13 kinase and mtor inhibitors
MX2023001876A (es) Derivados de rapamicina.
EA201270421A1 (ru) 1,2-дигидро-2-оксохинолиновые соединения в качестве лигандов рецептора 5-нт
MX2009005252A (es) Aminopirrolidinas como antagonistas del receptor de quimiocina.
JO3398B1 (ar) مشتقات 2،3- ثانى هيدرو- بنزو[1,4] أوكسازين والمركبات المتعلقة بها كمثبطات كيناز فسفواينوسيتيد-3 (pi3k) لمعالجة على سبيل المثال التهاب المفاصل الروماتيدي
MX2009012168A (es) Derivados de pirrolopiridina y su uso como inhibidores de la enzima que escinde la proteina precursora de amiloide por el sitio beta.
TW200833675A (en) Nicotinamide derivatives
EA201490807A1 (ru) Новые замещенные имидазопиримидины как модуляторы рецептора gpbar1
MX2012000231A (es) Nuevos aza-biciclo-hexanos.
MX353209B (es) Antagonistas d2, metodos de sintesis y metodos de uso.
PH12014502586A1 (en) Novel ring-substituted n-pyridinyl amides as kinase inhibitors
MX338551B (es) Nuevos compuestos de piridina fusionada como inhibidores de caseina quinasa.
MX337721B (es) Compuestos de heteroarilo como ligandos del receptor 5-ht4.
MX2012006789A (es) Derivados de etinilo.
MX339858B (es) Compuestos novedosos como ligandos del receptor h3 de la histamina.
WO2012172566A3 (en) Novel sglt inhibitors
EA201290610A1 (ru) Сульфоновые соединения в качестве лигандов 5-htрецептора
EA201270556A1 (ru) Конденсированные тиазоло и оксазолопиримидиноны
EA201290344A1 (ru) БИЦИКЛИЧЕСКИЕ СОЕДИНЕНИЯ В КАЧЕСТВЕ ЛИГАНДОВ αβНИКОТИНОВОГО АЦЕТИЛХОЛИНОВОГО РЕЦЕПТОРА
CY1117011T1 (el) Παραγωγα αζολιου
EA200970554A1 (ru) 4-(гетероциклил)алкил-n-(арилсульфонил)индолсоединения и их применение в качестве 5-нтлигандов
EA201390327A1 (ru) Гетероциклильные соединения в качестве лигандов гистаминовых hрецепторов

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU